# Fondaparinux

## Arixtra 2.5mg/0.5mL pre-filled syringe

| 藥物代碼           | IARI                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | ‧Deep venous thrombosis, acute, In conjunction with warfarin sodium‧Postoperative deep vein thrombosis, Hip repair or replacement, knee replacement, or abdominal surgery; Prophylaxis‧Pulmonary embolism, acute, In conjunction with warfarin sodium when initial therapy is administered in a hospital                                                                                                                                           |
| 副作用             | Common‧Dermatologic: Injection site reaction, Rash (7.5% )‧Other: Fever (13.6% )Serious‧Hematologic: Anemia (perioperative prophylaxis, 19.6%; extended prophylaxis, 1.5% ), Hemorrhage (2.2% to 3.4% ), Thrombocytopenia (0.04% to 0.2% (less than 50,000/mm(3)); 0.5% to 3% (50,000 to 100,000/mm(3)) )‧Immunologic: Anaphylaxis, Hypersensitivity reaction‧Neurologic: Extradural intracranial hematoma, Non-traumatic spinal subdural hematoma |
| 禁忌               | ‧Active major bleeding‧Bacterial endocarditis‧Body weight less than 50 kg in patients requiring prophylaxis for venous thromboembolism ‧History of serious hypersensitivity reaction (eg, angioedema, anaphylactoid or anaphylactic reactions)‧Severe renal impairment (ie, CrCl less than 30 mL/minute)‧Thrombocytopenia associated with positive in vitro test for antiplatelet antibody in the presence of fondaparinux sodium                  |
| 懷孕用藥危分級     | 可能安全                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| 孕期用藥建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 哺乳期用藥建議     | No (Limited) Human Data - Probably Compatible 無(很少)資料 - 可使用                                                                                                                                                                                                                                                                                                                                                                                |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 注射劑給藥建議途徑 | IVD, SC                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 輸注點滴液         | 【N/S】 可選                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| IVD 用法建議       | 成人:當首次劑量使用IVD方式投予時，將藥品加入25~50毫升的0.9%生理食鹽水，靜脈注射需超過2分鐘。                                                                                                                                                                                                                                                                                                                                                       |
| 注意事項           | 1.當血小板數值低於100,000/mm，不可使用本藥 2.本藥不可用於肌肉注射                                                                                                                                                                                                                                                                                                                                                                                  |

